PepGen Inc. (PEPG)
3.18
-0.03
(-0.93%)
USD |
NASDAQ |
Sep 09, 14:48
PepGen 1 Year Total Returns (Daily) : 115.4% for Sept. 8, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| September 08, 2026 | 115.4% |
| September 04, 2026 | 143.0% |
| September 03, 2026 | 167.2% |
| September 02, 2026 | 165.0% |
| September 01, 2026 | 169.0% |
| August 31, 2026 | 157.8% |
| August 28, 2026 | 152.5% |
| August 27, 2026 | 147.6% |
| August 26, 2026 | 153.5% |
| August 25, 2026 | 161.5% |
| August 24, 2026 | 141.7% |
| August 21, 2026 | 151.2% |
| August 20, 2026 | 146.7% |
| August 19, 2026 | 146.0% |
| August 18, 2026 | 123.8% |
| August 17, 2026 | 135.7% |
| August 14, 2026 | 131.8% |
| August 13, 2026 | 163.7% |
| August 12, 2026 | 154.4% |
| August 11, 2026 | 187.1% |
| August 10, 2026 | 179.4% |
| August 07, 2026 | 139.5% |
| August 06, 2026 | 75.91% |
| August 05, 2026 | 50.00% |
| August 04, 2026 | 45.11% |
| Date | Value |
|---|---|
| August 03, 2026 | 42.42% |
| July 31, 2026 | 28.47% |
| July 30, 2026 | 28.99% |
| July 29, 2026 | 23.91% |
| July 28, 2026 | 27.97% |
| July 27, 2026 | 31.03% |
| July 24, 2026 | 34.03% |
| July 23, 2026 | 43.84% |
| July 22, 2026 | 37.14% |
| July 21, 2026 | 60.61% |
| July 20, 2026 | 62.96% |
| July 17, 2026 | 66.67% |
| July 16, 2026 | 75.78% |
| July 15, 2026 | 93.55% |
| July 14, 2026 | 89.15% |
| July 13, 2026 | 93.65% |
| July 10, 2026 | 87.20% |
| July 09, 2026 | 94.92% |
| July 08, 2026 | 71.55% |
| July 07, 2026 | 84.68% |
| July 06, 2026 | 54.92% |
| July 02, 2026 | 45.45% |
| July 01, 2026 | 66.06% |
| June 30, 2026 | 62.16% |
| June 29, 2026 | 54.78% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 213.2% |
| Oncolytics Biotech, Inc. | -37.11% |
| Sangamo Therapeutics, Inc. | -69.35% |
| Sarepta Therapeutics, Inc. | 18.98% |
| Anixa Biosciences, Inc. | -2.68% |